Stem cell experts recognize the potential of exosomes for treating COVID-19 pneumonia, but caution that rigorous clinical testing is needed.
An international genetics consortium seeks to unravel the mystery of why COVID-19 infection is silent in some cases and lethal in others.
Understanding how closely related coronaviruses circulate seasonally could impact the timing of vaccination against SARS-CoV-2.
Two linear peptides identified by A*STAR researchers on the SARS-CoV-2 spike protein may improve the specificity of serological assays and show potential as vaccine candidates.
Lisa F. P. Ng, a leading infectious disease expert on infection and immunity, shares how her team’s prior experience has helped them quickly understand the nature of SARS-CoV-2, the virus that causes COVID-19.